Healthcare

A significant sell-off by top executives at telehealth provider Hims & Hers is raising red flags for investors, creating downward...

Bayer's stock finds itself at a pivotal juncture as investors weigh operational improvements against the company's pharmaceutical pipeline potential. The...

Investors showed renewed confidence in Capricor Therapeutics last week following a significant regulatory development from the U.S. Food and Drug...

The animal health sector leader Zoetis finds itself navigating turbulent market conditions, presenting investors with a perplexing scenario. While the...

The trading pattern of ZimVie shares has become remarkably predictable in recent weeks, consistently hovering near the $19 acquisition price...

Centene shares advanced 1.37% to $34.86 in the latest trading session, but investors are bracing for the company's true test...

The pioneering force in robotic surgery, Intuitive Surgical, is generating significant market enthusiasm from its Sunnyvale headquarters. As competitors scramble...

The leadership team at Redcare Pharmacy is undergoing a significant transition as the company's long-serving Chief Financial Officer announces his...

The telehealth sector, known for its rapid digital innovation, is facing increased regulatory scrutiny. Hims & Hers Health, Inc., a...

Eli Lilly finds itself navigating contrasting fortunes as the pharmaceutical giant simultaneously celebrates a major regulatory victory while confronting an...